Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00588211 · ClinicalTrials.gov registry record
Measurement of Cancer-Related Risk Perception in Smokers
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 1,514
- Enrollment target
NCT00588211: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00588211 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,514 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00588211 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 1,514 participants
- Enrollment target
Study Summary
The purpose of this study is to develop an accurate way of measuring people's thoughts about cancer risk. The researchers at the Queens Hospital Center, Memorial Sloan-Kettering Cancer Center and Adelphi University are working together to design a new measure. Findings from this study will help us find new ways to help people avoid cancer.
Interventions
- BEHAVIORAL Survey
- BEHAVIORAL Interviews
- BEHAVIORAL focus group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,514 participants |
| Start Date | 2001-09 |
| Est. Completion | 2022-09-13 |
What the finished NCT00588211 record still lists
NCT00588211 is an observational study that tracks outcomes without assigning an intervention. Its 1,514 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 3 interventions - of which Survey is the first listed.
NCT00588211 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00588211 about?
NCT00588211 is a clinical study titled "Measurement of Cancer-Related Risk Perception in Smokers". The purpose of this study is to develop an accurate way of measuring people's thoughts about cancer risk. The researchers at the Queens Hospital Center, Memorial Sloan-Kettering Cancer Center and Adelphi University are working together to design a new measure. Findings from this study will help us f...
What is the current status of trial NCT00588211?
This trial is currently completed. The enrollment target is 1,514 participants. The study started on 2001-09. Estimated completion is 2022-09-13.
What interventions are being tested in trial NCT00588211?
The interventions under investigation include: Survey (BEHAVIORAL), Interviews (BEHAVIORAL), focus group (BEHAVIORAL).
Who is sponsoring clinical trial NCT00588211?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05633654 · 1,514 participants · Phase 3
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
- NCT07136623 · 1,513 participants
Detecting Pulmonary Hypertension With the Eko CORE 500 Digital Stethoscope
- NCT07232017 · 1,520 participants
Implementation of Intensive Hypertension Management Approaches: Cleveland Clinic
- NCT06876714 · 1,524 participants · Phase 3
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia